Archives: Meet Our USA Fulbrighters

Anol Bhattacherjee

Dr. Anol Bhattacherjee is the Exide Professor in information systems and the director of the master’s program in artificial intelligence and business analytics at the University of South Florida. He has authored about 150 refereed publications, including 12 papers in Financial Times, 50 papers in journals, and seven papers in MIS Quarterly, the foremost journal in his discipline. For many years, he was on the editorial boards of MIS Quarterly and the Journal of the Association for Information Systems. With nearly 50,000 citations to his credit, a 2021 Stanford University study ranked him as number 12 in the world in career-wide research impact in the information systems discipline. Dr. Bhattacherjee has also authored a copyright-free book on research methods, Social Science Research: Principles, Methods, and Practices, which has been downloaded over 2 million times from 229 countries on six continents, used at over 10,000 institutions, and translated into seven languages. His many awards and honors include the Stafford Beer Medal by the Operational Research Society, UK, the Fulbright-Nehru Distinguished Chair in 2019, and the first-place award at the prestigious Institute of Industrial and Systems Engineers (IISE) Innovation Cup Competition in 2023.

Dr. Bhattacherjee’s Fulbright-Nehru project is designing AI systems for societal good – such as to reduce societal polarization – and conducting behavioral experiments in terms of the use of these systems by the population and the impacts of such use. The project is collaborating with Indian scholars to conceptualize, design, conduct, and publish research on this topic and related ones. The project also serves several key objectives of the Government of India’s initiatives related to leveraging technology and science for societal benefit and improving human and institutional capacity for scientific research.

Tanvi Banerjee

Dr. Tanvi Banerjee is an associate professor in the Department of Computer Science and Engineering at Wright State University, where she also serves as the codirector of the Data Science for Healthcare Lab. She holds a PhD and an MS in electrical and computer engineering from the University of Missouri.

Dr. Banerjee’s core research interest lies at the intersection of computing and medicine, where she focuses on healthcare applications that utilize wearable and non-wearable sensors for chronic disease management, including measuring stress in caregivers of dementia patients. Her work extensively employs machine learning techniques, data fusion, and big data analytics to classify complex sensor data. With an h-index of 27, her publications cover topics such as multimodal data analysis, physiological responses, and predictive modeling for conditions like sickle cell disease, dementia, and chronic pain. Throughout her career, she has secured substantial research funding, with her personal share of grants totaling approximately USD 2.5 million from prestigious institutions such as the National Institutes of Health (NIH), the Department of Energy, and the Air Force Research Laboratory (AFRL). An accomplished educator, she was honored with Wright State’s College of Engineering and Computer Science’s Teaching Award for the 2024–2025 academic year. Her leadership role in the scientific community is reflected in her position as an associate editor for IEEE Transactions on Artificial Intelligence and as local chair and program committee member for several international conferences.

An estimated 8.8 million Indians above the age of 60 live with dementia, yet most remain undiagnosed and lack access to essential resources. To bridge this gap, Dr. Banerjee’s Fulbright-Nehru research project is proposing a culturally nuanced, region-specific Dementia Assessment tool tailored for rural communities. This will enable patients to securely share high-frequency cognitive assessments with their care providers. By deploying AI models to forecast symptom progression, the tool can empower clinicians to deliver proactive interventions and personalized treatment courses, thereby ultimately transforming rural dementia care in India.

Udita Gupta

Dr. Udita Gupta is a clinical associate professor in the Urban Institute for Teacher Education (UITE) at the University of Utah’s College of Education, where she is working in the field of teacher preparation and secondary mathematics education. She began her career as a statistics lecturer in India. She completed her PhD in educational psychology (learning sciences) from the University of Utah. Dr. Gupta brings a cross-cultural perspective shaped by her academic and professional experience in both India and the United States, and is fluent in both Hindi and English. Her research focus is on the cognitive load incurred in STEM learning; reflective practices; global competency development; community-engaged learning; and the integration of artificial intelligence in teacher preparation. She is particularly interested in how culturally responsive pedagogy, global perspectives, and AI-enhanced instructional strategies can strengthen preservice and in-service teacher education. She has published scholarly work and led faculty development initiatives in these areas.

Dr. Gupta’s Fulbright-Nehru project has three major components: strengthening preservice teacher preparation and secondary mathematics teaching methods through direct classroom teaching, workshops, and seminars for both preservice and in-service teachers in India; collaborating with Indian faculty on developing a curriculum that integrates culturally responsive pedagogy, global aspects, and AI into teacher education; and building enduring academic partnerships between Indian and U.S. institutions through sustained mentorship and capacity building in STEM teacher education. Aligned with India’s National Education Policy (NEP) 2020 reforms that emphasize critical thinking over rote learning, the project is working toward strengthening STEM teacher preparation through inquiry-driven, student-centered strategies, and adopting global practices like COIL – Collaborative Online International Learning.

Praveen Arany

Dr. Praveen Arany is a trained dentist, oral pathologist, and biomedical engineer. He served as an assistant clinical investigator at NIDCR/NIH, Bethesda, and is currently an associate professor with tenure at the University at Buffalo, New York. He has six patents, over 150 scientific publications with over 12,000 citations, and an h-index of 43. His research has been featured in many mainstream media highlights in over 70 countries. He has also received numerous awards recognizing his research contributions, such as the Excellence in Research award from the World Association for Photobiomodulation Therapy (WALT), the Young Investigator award from the National Cancer Institute/NIH, the Young Investigator Award from the Wound Healing Society, the Horace Furumoto Young Investigator award from the American Society for Laser Medicine and Surgery, and the Theodore Maiman Award from the Academy of Laser Dentistry. He is the chair of the photobiomodulation (PBM) group in Optica and the former president of WALT, NAALT (North American Association for Photobiomodulation Therapy), and the Lasers & Bio-photonics Group of the International Association of Dental Research.

Dr. Arany has been a key figure in organizing the field of PBM. As an intramural investigator at NIDCR/NIH and in a leadership position at WALT and NAALT, he was instrumental in the adoption of the nomenclature for PBM as an MeSH term for PubMed. Among his other achievements are the demonstration of a novel PBM molecular mechanism involving latent TGF-beta 1 activation, and outlining clinical biomarkers, molecular biomarkers, treatment delivery, and dosimetry. Most recently, he advocated for procedural (insurance) codes to enable safe and effective PBM clinical protocols. This has resulted in clinical practice guidelines recommendations for treating several human diseases and promoting wellness, especially in supportive cancer care.

In India, oral cancer affects over a million people annually. Dr. Arany’s Fulbright-Nehru project is introducing the non-invasive, low-dose, and light PBM therapy for oral cancer patients in India, which has been proven to significantly improve both quality of life and quality of care.

Javad Anjum

Dr. Javad Anjum is an assistant professor in the Department of Communication Sciences and Special Education at the University of Georgia. He earned an MBBS, a bachelor’s in medicine, and a bachelor’s in surgery, in India. He subsequently worked as a junior resident in the Department of Psychiatry and later pursued clinical research in the Department of Neurophysiology at the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru, India. He then completed an MEd in educational research and evaluation and a PhD in speech-language science, both from Ohio University. Dr. Anjum also holds a Certificate of Clinical Competence in Speech-Language Pathology (CCC-SLP) from the American Speech-Language-Hearing Association (ASHA).

Dr. Anjum’s overarching research agenda focuses on enhancing cognitive and communication outcomes for individuals affected by aphasia, a language disorder that often occurs after focal brain damage such as a stroke, and for individuals with dementia, a neurodegenerative condition that commonly affects both cognition and communication. He approaches this work through three interconnected lines of inquiry: examining the cognitive and lexical-semantic mechanisms that underlie language performance in people with aphasia and dementia; advancing equitable, person-centered neurorehabilitation models for multilingual people with aphasia and dementia; and developing interdisciplinary training programs to strengthen clinical service delivery for people with aphasia and older adults experiencing cognitive decline and dementia. His Fulbright-Nehru Scholar Award extends this third line of inquiry.

The aim of Dr. Anjum’s six-month Fulbright-Nehru flex project is to develop, implement, and evaluate an interdisciplinary cognitive enhancement program for older adults in Mysuru district. Toward this, it is tailoring evidence-based cognitive stimulation activities (brain exercises) that are culturally sensitive and linguistically appropriate for Indian families. Graduate students in public health and speech-language pathology are also part of the project; they are being trained to implement the program in 25 households, scaling up to an additional 50 households through telepractice at no cost to the recipients. The project is expected to create a sustainable model to improve cognitive health and delay dementia among older adults in India.

Ashley Walsdorf

Dr. Ashley Walsdorf is an assistant professor of couple and family therapy at Alliant International University. She received her PhD in human development, family science, marriage, and family therapy from the University of Georgia in 2019, with a specialization in immigration policy and working with multicultural communities. In addition to her work at Alliant, Dr. Walsdorf is a licensed, bilingual marriage and family therapist and an AAMFT-approved supervisor in the state of Texas, the director of family programming at a residential treatment center, and a research affiliate of the Latino Research Institute at the University of Texas at Austin. Clinically, she has been practicing therapy in English and Spanish with individuals, couples, and families for nearly 15 years, specializing in work with immigrant families, multicultural communities, and addiction and recovery. Her research has examined ethnic-racial socialization, the effects of U.S. socio-political climate on mental health among Latino communities, affirmative clinical work with LGBTQ communities, and critical race theories. She has authored over 25 peer-reviewed journal articles and book chapters, and presented her work at more than 50 national and international conferences. Dr. Walsdorf’s connection to India and international work is both professional and personal: her husband and stepdaughter are from Kerala, and her blended, cross-cultural family informs her commitment to systemic and culturally responsive family therapy. She loves traveling and cooking with her family and eating her mother-in-law’s seriously spicy food.

Dr. Walsdorf’s Fulbright-Nehru project is examining the relevance of systemic family therapy in the South Indian context. Based at Rajagiri College of Social Sciences in Kochi, Kerala, she is collaborating with graduate students and faculty in psychology and social work through coursework and participatory research that assess Western family therapy theories and models for “cultural fit”, while developing adaptations for local family and community contexts. Her project aims to create culturally responsive frameworks that strengthen the relational elements of mental health education while honoring South Indian social and familial dynamics, in addition to fostering India–U.S. academic partnerships.

Rohini Iyengar Vadapalli

Dr. Rohini Iyengar Vadapalli is an art historian and an academician. Apart from research and teaching, she engages in curatorial practice. She obtained her PhD in art history from the Maharaja Sayajirao University of Baroda, India. She has significant experience in teaching art history courses at several universities and colleges in India and the U.S. She has also presented her research at various national and international conferences.

Her primary research focuses on regional aesthetics and the various factors affecting the nuances of regional artistic identities. A secondary area of interest is the premodern visual traditions of India. Her publications include exhibition catalogues, magazines, peer-reviewed essays in art journals, and edited textbooks on art and art history.

Dr. Vadapalli’s Fulbright-Nehru project is tracing the development of twenty-first-century visual arts in Telangana and Andhra Pradesh in India as well as New Jersey and New York in the Mid-Atlantic region of the U.S. by drawing some compelling parallels between the living folk traditions of both the regions. The study is comparing and contrasting these two regions based on the economic-technological and politico-religious aspects affecting the arts. Her research is also highlighting the importance of AI in various art spheres. The project aims to enable the introduction of new courses on regional contemporary art and curatorial studies in New Jersey and New York, as well as courses on the “histories of regional modern Indian art” in academic institutions. It also holds interdisciplinary relevance for furthering scholarship on American regionalism studies. Further, it would provide database for art historians to conduct research both in the U.S. and India. Most significantly, this project is expected to contribute immensely to the field of art history.

Deodutta Roy

Prof. Deodutta Roy is a professor emeritus at the Robert Stempel College of Public Health & Social Work at Florida International University (FIU), Miami. He joined FIU as a professor in 2004 and served as the founding chairman of the Department of Environmental and Occupational Health from 2005 to 2011. Prior to FIU, he was a tenured professor at the University of Alabama at Birmingham (1998–2004). His leadership in building the Department of Environmental and Occupational Health at FIU established him as a key figure in public health academia.

Nationally and internationally recognized for advancing translational exposomics –bridging genome, exposome, and environmental public health – Prof. Roy has received several prestigious awards, including the Junior Faculty Development Award from the American Cancer Society, the Scholar Award in Cancer Research from the American Association for Cancer Research, and the Fulbright Senior Scholar Award. He has published over 150 peer-reviewed articles, book chapters, and monographs, and holds two patents. He has trained 15 doctoral students and numerous postdoctoral fellows. His work has garnered over 6,000 citations on ResearchGate, underscoring the breadth of his scholarly influence.

Prof. Roy has been at the forefront of exposomics research, exploring how environmental DNA and RNA can serve as records of the human exposome, and can help in understanding the environmental causes of chronic diseases. His work integrates machine learning and bioinformatics to analyze complex, multi-omics datasets, and advancing computational approaches to environmental health sciences, brain health, and cancer research.

Dr. Roy’s Fulbright-Nehru project is integrating teaching, curriculum development, and collaborative research to advance environmental public health education and exposomics research at Amity University, Haryana. Focusing on the air quality in the Delhi National Capital Region, it is exploring links between environmental DNA and early brain health. The curriculum incorporates exposomic methods and analytical tools, alongside holding of workshops and boot camps. By addressing the challenges of air pollution and neurodevelopmental risks in children, the project aims to build institutional exposomics capacity and fulfill the Fulbright mission by fostering academic collaborations between the United States and India.

Sreejayan Nair

Dr. Sreejayan Nair, PhD, MPharm, FAHA, is professor of pharmacology, chair of the Division of Pharmaceutical Sciences, and director of the Biomedical Sciences PhD Program at the University of Wyoming, and also serves as the pharmacology thread lead for the WWAMI Medical School, overseeing integrated pharmacology education for medical students. He received his PhD from the College of Pharmaceutical Sciences, Manipal, India, and completed his postdoctoral training at the Department of Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-Universität, Germany, and the Department of Physiology and Pharmacology, University of Tennessee Health Science Center, U.S. Dr. Nair has over 30 years of experience in pharmacology education, translational research, and mentorship, with his research focusing on protease biology and translational therapeutics for diabetes complications, cardiovascular disease, and neuroinflammation. He has led projects funded by the National Institutes of Health (NIH), the American Heart Association (AHA), and the American Diabetes Association (ADA), and has received multiple industry grants, supporting both basic discovery and translational applications. He has also authored over 100 peer-reviewed publications. A co-founder of two pharmaceutical start-ups, Dr. Nair holds patents in protease-targeted therapeutics, and has served as the principal investigator on NIH SBIR/STTR grants for bridging academic research and commercial innovation. He also serves as the mentoring director for the WY-NIH Sensory Biology COBRE, providing structured guidance to junior faculty. His teaching has been consistently recognized with honors such as the Ellbogen Meritorious Classroom Teaching Award and the Entrepreneur Award at the National IDeA Symposium of Biomedical Research Excellence. He has also contributed to the training of PhD, postdoctoral, graduate, and undergraduate students.

Dr. Nair’s Fulbright-Nehru project is integrating teaching and research to enhance pharmacology education and translational drug discovery at BITS Hyderabad. As part of the project, he is teaching a molecular pharmacology course, mentoring graduate students, and collaborating on molecular pharmacology/drug discovery projects related to diabetes complications and neuroinflammation. By combining classroom instruction with hands-on research and mentoring, the project aims to strengthen student training, support BITS’s PhD-IMPACT/DRIVE initiatives, and foster long-term Indo-U.S. collaborations in pharmacology and therapeutic innovation.

Suraj Muley

Dr. Suraj Muley is a neurologist and internationally recognized expert in neuromuscular medicine, neuroimmunology, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy (CIDP). He serves as director of neurology at Bob Bové Neuroscience Institute at HonorHealth and is professor of medicine at Arizona State University School of Medicine and Advanced Medical Engineering. Dr. Muley completed his medical education at Seth Gordhandas Sunderdas Medical College, Mumbai, which was followed by research training in pharmacology and residency and fellowship training in neurology, clinical neurophysiology, and neuromuscular diseases at the University of Minnesota. He is board certified in neurology, clinical neurophysiology, and neuromuscular medicine.

Over a distinguished academic career spanning more than three decades, Dr. Muley has held major leadership roles at the University of Minnesota, Barrow Neurological Institute, and HonorHealth, including directing neuromuscular, neuroimmunology, fellowship, and residency programs. His clinical and research interests focus on immune-mediated neuromuscular disorders, with emphasis on novel targeted therapies for myasthenia gravis and CIDP. He has served as principal investigator or co-investigator on numerous national and international clinical trials in neuromuscular diseases.

Dr. Muley has authored and co-authored numerous peer-reviewed publications, book chapters, invited reviews, and international presentations in neuromuscular medicine. He is a Fellow of the American Academy of Neurology (FAAN), Fellow of the American College of Physicians (FACP), and Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin). His honors include multiple teaching and research awards.

Dr. Muley’s Fulbright-Nehru project is focusing on advancing neuromuscular medicine and neuroimmunology in India through collaborative teaching, research, and clinical training. Working with leading academic medical centers in Mumbai, his project emphasizes inflammatory neuropathies and myasthenia gravis, with particular focus on advanced electrophysiological techniques and emerging targeted therapies. The project aims to strengthen subspecialty education, promote collaborative clinical research, and develop sustainable academic partnerships between Indian and U.S. institutions. By leveraging India’s large and diverse patient population, the project seeks to improve understanding and treatment of immune-mediated neurological disorders while fostering long-term global collaboration in neuroscience.